Blog
This section tackles multiple topics around the CBD industry, such as regulatory developments, case studies, court cases, market impact, sales predictions, etc. These and other critical issues are explored in our blog posts, written by our in-house team of industry experts.
What can be concluded from the appointment of Lina Khan as new chair of the Federal Trade Commission (FTC)?
Written by CBD-Intel || 22nd July 2021 || Blog |
Lina Khan's appointment to chair the US Federal Trade Commission (FTC) – confirmed last month – was a bit of a surprise ...
EU novel food assessment: No easy end in sight
Written by CBD-Intel || 16th July 2021 || Blog |
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented? ...
Why the UK government might not follow task force advice on homegrown hemp
Written by CBD-Intel || 8th July 2021 || Blog |
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented? ...
UK taskforce urges reform – but will it happen, and will it boost the market?
Written by Freddie Dawson || 28th June 2021 || Blog |
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented? ...
Why is crowd-funding an increasingly popular option for CBD companies to raise investment?
Written by JuditBach || 21st June 2021 || Blog |
Nordic Oil’s announcement of a crowd-funding launch on Seedrs is the latest in a growing queue of crowd-funding announcements. There are several reasons why even large CBD brands are increasingly turning towards crowd-funding as a method for raising...
What changes can be expected in the near future for the regulation of CBD in France?
Written by JuditBach || 11th June 2021 || Blog |
A draft proposal clarifying CBD regulations in France could lead to further enforcement on the sales of CBD products – heavily impacting the current make-up of the French market in the process. The draft arrêté, not publicly available...
New UK cannabis industry body brings together a wide range of expertise
Written by CBD-Intel || 3rd June 2021 || Blog |
A new UK cannabis industry association claims to be the first to bring together members from every aspect of the industry – with a range of more than 100 members already ...
Is delta-8 THC a legal product in the US?
Written by CBD-Intel || 20th May 2021 || Blog |
CBD-Intel’s opinion from a reading of laws at the federal level is that – currently – delta-8 THC should be considered legal if derived from a legal hemp plant. This is because the federal definition of hemp encompasses...
What can we learn from the distribution of brands by main product category and retailer type in the UK?
Written by CBD-Intel || 14th May 2021 || Blog |
CBD-Intel’s new UK online report highlights a number of interesting market developments. Among them is the information that brand distribution provides. From a dominance perspective, more brands are now being listed for cosmetic than vape products. This shows...
Could CBD/hemp vaping equipment be exempt from the incoming rule prohibiting the mailing of e-cigarette and vaporiser-related products through the US Postal Service (USPS)?
Written by CBD-Intel || 7th May 2021 || Blog |
Recent consultation guidance does suggest that the USPS is considering broadly exempting hemp and CBD services from the incoming rule. The guidance states: “For hemp-based products containing CBD with a THC concentration not exceeding 0.3 percent, mailers must...
What is the state of science behind minor cannabinoids really like?
Written by CBD-Intel || 29th April 2021 || Blog |
Minor cannabinoids are gaining increasing interest – pushed by both slowly growing consumer awareness and companies looking to develop further revenue streams from under-utilised products. A number of claims have been made about the properties of various minor...
How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?
Written by CBD-Intel || 22nd April 2021 || Blog |
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in...
Is delta-8 THC really the next big thing?
Written by CBD-Intel || 14th April 2021 || Blog |
From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies...
Should CBD companies operating in the US be worried about the latest round of FDA enforcement?
Written by CBD-Intel || 8th April 2021 || Blog |
Four new letters sent by the US Food and Drug Administration (FDA) in the month of April mark a bit of a change in approach. Two of them were fairly standard warnings about health claim marketing potentially in...
Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?
Written by CBD-Intel || 1st April 2021 || Blog |
The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the...
Was the UK FSA decision to make changes to the novel food application timeline really that unexpected?
Written by CBD-Intel || 25th March 2021 || Blog |
The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that...
With ingredient prices tumbling, why are CBD consumers still paying so much?
Written by Nate Erskine || 18th March 2021 || Blog , Business briefing |
A drop in the cost of bulk CBD has not yet been wholly reflected in falling CBD product prices – but are we about to witness a perfect storm for a race to the bottom? ...
Will the FSA-validated novel food submission list reveal commercially sensitive information?
Written by CBD-Intel || 11th March 2021 || Blog |
There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient...
How long will it take to see validated assessments from the UK Food Standards Agency (FSA)?
Written by CBD-Intel || 4th March 2021 || Blog |
The FSA has confirmed to CBD-Intel that it has already validated at least one application with an updated list to be published in April. This represents a significantly quicker turnaround than many anticipated, though Pureis did submit its...
Could the Biden administration bring a new approach to enforcement of CBD health claims?
Written by CBD-Intel || 26th February 2021 || Blog |
There is a chance that enforcement priorities could change under new appointments to the Federal Trade Commission (FTC) by the Biden administration. Two commissioners – one of which is staying on to work as part of the Republican minority...
Have the rules changed for importation of CBD into the UK?
Written by CBD-Intel || 18th February 2021 || Blog |
The Home Office has not changed licensing requirements for importers of CBD into the UK. The minister for policing, Christopher “Kit” Malthouse, has requested an updated recommendation from the Advisory Council on the Misuse of Drugs (ACMD) on acceptable...
Will the EFSA look to modify its approach in light of action on novel food in the UK?
Written by CBD-Intel || 12th February 2021 || Blog |
The European Food Safety Authority (EFSA) has stated that it is in contact with other similar agencies such as the Food Standards Agency (FSA) in the UK, but only specified that it would not treat applications that had been approved...
How seriously should producers of CBD alcohol products take the recent Portman Group ruling?
Written by CBD-Intel || 5th February 2021 || Blog |
The Portman Group’s first decision on a complaint regarding a CBD product has gone largely unreported but could have a very significant impact on that part of the market. The voluntary alcohol industry regulator has said it is bringing...
What impact will the EC’s decision to permit the use of extracts from the whole plant in cosmetics have on the industry as a whole?
Written by CBD-Intel || 28th January 2021 || Blog |
The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market....
Is the entrance of British American Tobacco (BAT) into the CBD sector a positive or negative for the industry?
Written by CBD-Intel || 22nd January 2021 || Blog |
The top-line answer is that it is wholly neither. There are elements of both in any position taken on the news. BAT’s entrance into the market with its vaping product under the Vuse brand (coming in three flavours – mint, mango...
Does the Canopy CO2 extraction lawsuit pose a threat to others in the industry?
Written by CBD-Intel || 15th January 2021 || Blog |
Canopy Growth’s quick action – filing a suit against GW Pharmaceuticals the day the patent was issued – coupled with the short time-frame for validity has left many worried that the company could go on an enforcement hunt...
What impact do Democrat victories in both of the Georgia senate seat elections have on chances for cannabis reform at the US federal level?
Written by CBD-Intel || 8th January 2021 || Blog |
President elect Joe Biden still looks to be somewhat reluctant to too closely embrace cannabis reform as an issue. But effective control of the senate through victories by Raphael Warnock and Jon Ossoff in special run-off elections in...
Do CBD firms expect much of a January uptick in sales?
Written by CBD-Intel || 18th December 2020 || Blog |
It seems many of the firms CBD-Intel has talked to see a similar story for January sales, focused on resolutions or upticks in health and wellness – as was predicted for the holidays sales period stretching from Black...
How far-reaching an impact could the CJEU Kanavape decision have?
Written by CBD-Intel || 11th December 2020 || Blog |
The Court of Justice of the European Union’s (CJEU) decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. A...
What does the European Commissions (EC)’s change in opinion on CBD as a narcotic mean?
Written by CBD-Intel || 4th December 2020 || Blog |
The announcement is a full reversal from the EC on a position that many found surprising in the first place. It marks a stellar period for the regulation of CBD and other cannabinoids with major decisions in their...
What impact will Black Friday sales have on the CBD sector?
Written by CBD-Intel || 27th November 2020 || Blog |
Overall it seems the industry – particularly in Europe – is not expecting much from Black Friday sales. European companies appear to consider CBD products more as health products that are requirement purchases throughout the year as opposed to lifestyle products that might be...
How important is the CJEU decision on the Kanavape case?
Written by CBD-Intel || 20th November 2020 || Blog |
How important is the CJEU decision on the Kanavape case? The judgement in favour of CBD from the Courts of Justice of the European Union (CJEU) will almost certainly have significant long-term consequences for the CBD industry in Europe....
Where are we most likely to see changes to medical and recreational cannabis regimes?
Written by CBD-Intel || 13th November 2020 || Blog |
Mexico is overall the number one country to watch, rated highly likely to change regulations on both medical and recreational cannabis in the near...
What can be referenced from cannabis victories in the US general election?
Written by JuditBach || 6th November 2020 || Blog |
It looks like a clean sweep for pro-cannabis referendums in US states. But much work will still need to be done with state legislatures having to design and pass regulatory structures for each...
What impact could the vote to support a 0.3% THC limit in hemp varieties have on the CBD market in the short-term?
Written by CBD-Intel || 30th October 2020 || Blog |
In short – not a lot in the short-term. The vote in favour of a 0.3% THC limit by the European Parliament (EP) is only the first step in a long process towards actually putting such a change into...
What impact could a decision in the recent Dusseldorf lawsuit have on the German CBD sector?
Written by CBD-Intel || 23rd October 2020 || Blog |
The company of the president of the European Industrial Hemp Association (EIHA) has challenged a ban on the sale of all foods containing...
What impact will the US elections have on CBD and cannabis?
Written by CBD-Intel || 16th October 2020 || Blog |
It's important to remember that all aspects of cannabis and CBD – even federal decriminalisation or legalisation...
Do companies need toxicological study data included in UK Food Standards Agency (FSA) novel food applications for them to be validated?
Written by CBD-Intel || 9th October 2020 || Blog |
There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data...
Is increased uncertainty in established markets driving interest in secondary markets such as Asia?
Written by CBD-Intel || 2nd October 2020 || Blog |
There has been increased interest in secondary markets that has resulted in some positive...
What impact does the delay in voting on the MORE Act have on the CBD industry?
Written by CBD-Intel || 25th September 2020 || Blog |
The Marijuana Opportunity Reinvestment and Expungement (MORE) Act was, of course, always more about cannabis than hemp-derived CBD specifically. And, as previously stated, its chances of passing were slim to...
Why do bills related to cannabinoids keep getting pushed through the US Congress?
Written by CBD-Intel || 21st September 2020 || Blog |
There does not seem to be much point in continuing to try to force through bills – particularly given that the Republican-controlled senate and presidency opposes any measures and the limited timeframe before the end of the legislative session....
Is the argument against classing CBD as a narcotic quite as clear-cut as they say?
Written by Freddie Dawson || 11th September 2020 || Blog |
What should the industry make of the recent paper from 11 industry associations putting forward a unified position on the issues surrounding the potential for CBD to be considered a narcotic? ...
What impact would the US Drug Enforcement Agency (DEA) rules have on the CBD industry if they were enacted in their current form?
Written by CBD-Intel || 4th September 2020 || Blog |
First it's important to note that the DEA proposals are only in a draft form and are open to comment until 20th October. They have already received a large number of comments, the majority of which appear to...
How significant is Charlotte’s Web being denied a trademark?
Written by CBD-Intel || 27th August 2020 || Blog |
The immediate impact of the decision is a reduction in certainty for CBD firms - not something they need at a time of significantly heightened uncertainty in other...
What can be made of Canopy’s increased interest in functional ingredients?
Written by CBD-Intel || 21st August 2020 || Blog |
Canopy, the Canadian cannabinoid company, has continued to commit heavily to BioSteel, a sports nutrition company in which Canopy now owns the majority share....
Why does the European Commission (EC) think CBD may be a narcotic?
Written by CBD-Intel || 14th August 2020 || Blog |
The opinion (which is not yet set by the EC but appears to be the way the organisation is thinking) is based on a literal reading of the 1961 UN Narcotics...
What can we expect from the US Food and Drug Administration (FDA) proposals to regulate CBD under review by the White House Office of Management and Budget (OMB)?
Written by CBD-Intel || 7th August 2020 || Blog |
Authorities have been very tight lipped about the details of the proposed regulations and little is known beyond the title of the document....
Now that Swiss authorities have returned taxes, what is the industry planning to do?
Written by CBD-Intel || 31st July 2020 || Blog |
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un...